Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-10-13
1995-06-13
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 23, 514885, 536114, 536118, 536122, 53612312, 426800, 426810, A61K 3170, A61K 31715
Patent
active
054243009
ABSTRACT:
An agent for treatment of chronic fatigue syndrome, which comprises a polysaccharide having a .beta.-1,3-glucoside bond in the main chain as an effective ingredient.
REFERENCES:
patent: 3819480 (1974-06-01), Hochschild
patent: 4281009 (1981-07-01), Konishi
patent: 5013739 (1991-05-01), Bihari et al.
patent: 5055296 (1991-10-01), Wagle et al.
patent: 5118673 (1992-06-01), Carpenter et al.
patent: 5126376 (1992-06-01), Herman
patent: 5155032 (1992-10-01), Tanaka et al.
patent: 5162037 (1992-11-01), Whitson-Fischman
patent: 5189022 (1993-02-01), Bridge et al.
patent: 5236709 (1993-08-01), Soma et al.
Elisabeth Keiffer "The Illness You Can't Sleep Off", Woman's Day, Mar. 1, 1990, pp. 26,30,31 and 32.
Karen Garloch "Lab Test Pinpoints Chronic Fatigue", The Charlotte Observer, Monday, Nov. 19, 1990, pp. 1A and 7A.
Andrew Lloyd et al, "A Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin Therapy in Patients with Chronic Fatigue Syndrome." The American Journal of Medicine, vol. 89, Nov. 1990, pp. 561-568.
Lien, "Fungal Metabolites and Chinese Herbal Medicine as Immunostimulants," Prog. Drug. Res., vol. 34, pp. 395-420 (1990).
G. Chihara et al, "Current Status and Perspectives of Immunomodulators of Microbial Orgin", Int. J. Tiss. Reac. IV (3) 207-225 (1982).
Griffin Ronald W.
Kaken Pharmaceutical Co.
LandOfFree
Method for treatment of chronic fatigue syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of chronic fatigue syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of chronic fatigue syndrome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1309408